載入...
Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease
OBJECTIVE: In this study, we assessed plasma biomarkers to identify cognitive impairment in Parkinson’s disease (PD) patients by applying ultra-sensitive immunomagnetic reduction-based immunoassay (IMR). METHODS: The study enrolled 60 PD patients and 28 age- and sex-matched normal controls. Complete...
Na minha lista:
| 發表在: | Front Aging Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7198695/ https://ncbi.nlm.nih.gov/pubmed/32410983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2020.00112 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|